CN110184191A - A kind of raising lactobacillus bulgaricus is stored at room temperature and the freeze drying protectant of anti-pressure ability and its application - Google Patents

A kind of raising lactobacillus bulgaricus is stored at room temperature and the freeze drying protectant of anti-pressure ability and its application Download PDF

Info

Publication number
CN110184191A
CN110184191A CN201910482027.1A CN201910482027A CN110184191A CN 110184191 A CN110184191 A CN 110184191A CN 201910482027 A CN201910482027 A CN 201910482027A CN 110184191 A CN110184191 A CN 110184191A
Authority
CN
China
Prior art keywords
freeze
lactobacillus bulgaricus
parts
drying
freeze drying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910482027.1A
Other languages
Chinese (zh)
Other versions
CN110184191B (en
Inventor
刘彦民
黄少磊
夏少明
李林泉
刘云辉
李康宁
李晓军
郭跃东
马跃英
王海霞
邢会霞
王春颖
冯谦
程超
马晓红
杨飞雁
田鑫
张春霞
韩至
赵晓燕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NEI MONGGOL SHUANGQI PHARMACEUTICAL CO Ltd
Original Assignee
NEI MONGGOL SHUANGQI PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NEI MONGGOL SHUANGQI PHARMACEUTICAL CO Ltd filed Critical NEI MONGGOL SHUANGQI PHARMACEUTICAL CO Ltd
Priority to CN201910482027.1A priority Critical patent/CN110184191B/en
Publication of CN110184191A publication Critical patent/CN110184191A/en
Application granted granted Critical
Publication of CN110184191B publication Critical patent/CN110184191B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04Preserving or maintaining viable microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02WCLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
    • Y02W90/00Enabling technologies or technologies with a potential or indirect contribution to greenhouse gas [GHG] emissions mitigation
    • Y02W90/10Bio-packaging, e.g. packing containers made from renewable resources or bio-plastics

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention belongs to probiotic composition preparation technical fields, and in particular to a kind of preparation process that lactobacillus bulgaricus can be improved and be stored at room temperature the freeze drying protectant and freeze-dried vaccine powder of ability and anti-pressure ability.Lactobacillus bulgaricus bacterium powder prepared by the present invention has high stability and extremely strong anti-pressure ability at normal temperature, viable bacteria loss can be especially significantly reduced in tablet process, improve product yield, it can be avoided the cold chain transportation of lactobacillus bulgaricus product, reduce its selling cost, its anti-pressure ability is improved simultaneously, reduces production cost.

Description

A kind of raising lactobacillus bulgaricus is stored at room temperature the freeze drying protectant with anti-pressure ability And its application
Technical field
The invention belongs to probiotic composition preparation technical fields, and in particular to lactobacillus bulgaricus room temperature can be improved in one kind The freeze drying protectant and its freeze-dried vaccine powder preparation technique of hold capacity and anti-pressure ability.
Background technique
Lactobacillus bulgaricus (L.delbrueckii subsp.bulgaricus) is Lactobacillus delbrueckii (L.delbrueckii) subspecies in kind, Gram-positive, negative catalase do not move, and no gemma is facultative to detest Oxygen.DSShi lactobacillus subspecies bulgaricus is one of most important lactic acid fermented agent strain, during the fermentation can be through homotype cream Lactose conversion is lactic acid by acid fermentation, and is peptides and amino acid by protein degradation, provides unique matter for dairy products Ground, flavor, while assigning dairy products special dietotherapy effect, dairy products functionality and nutritive value are also improved, is being sent out There is very important economic value in kefir milk industry.As people go deep into lactobacillus bulgaricus research, except can use In outside ferment agent for sour milk, itself has and improve the immunity of the human body, adjust the important physiology such as intestinal flora, improvement function of intestinal canal And healthcare function.Therefore, more and more the probiotic composition containing lactobacillus bulgaricus in terms of medical treatment, health care and nutrition Obtain promotion and application.
Since lactobacillus bulgaricus itself is more fragile, it is highly prone to temperature, pH, gas componant, mechanicals efforts etc. The influence of extraneous factor and cause number of viable reduce and effect reduce.To ensure that there is higher viable count in shelf life And beneficial function, most probiotic products containing lactobacillus bulgaricus are needed through cold chain transportation and low-temperature storage Mode is sold, and strong influence and limits the application mode and product effect of product, while improving product cost, into And influence the sale of product.Further, since lactobacillus bulgaricus is poor to the tolerance of mechanical stress, in its preparation processing Viable bacteria loss is larger in production process, leads to that the production cost increases, production efficiency decline.Therefore, lactobacillus bulgaricus is promoted The promotion of manufacturing enterprise's production efficiency is related to the tolerance of environment and related probiotics preparation more preferably and is widely answered With.
Chinese patent CN102952755A discloses a kind of freeze drying protectant of lactobacillus bulgaricus, by lactose 20~30 Part, 20~30 parts of skimmed milk powder, 3~5 parts of sodium ascorbate, 0.2~0.6 part of Macrogol 4000, polyvinylpyrrolidone 0.2 ~0.8 part, 0.5~2.0 part of bovine serum albumin(BSA) and 100 parts of distilled water compositions.Since component is excessive, it is not very convenient to prepare, Meanwhile its anti-pressure ability is not required during the preparation process.
Since lactobacillus bulgaricus bacterium powder is prepared by freeze-drying at this stage, screening and optimization Frozen-dried protective agent prescription, adjustment parameters of freeze-drying process become promoted lactobacillus bulgaricus to environmental resistance the most directly and Effective means.
Summary of the invention
The technical problem to be solved by the present invention is to overcome the weakness that lactobacillus bulgaricus self tolerance is poor, provide one The lactobacillus bulgaricus freeze drying protectant and its freeze-dried vaccine powder preparation technique of kind high activity, strong resistance, can be significant That improves lactobacillus bulgaricus is stored at room temperature ability and anti-pressure ability.
To achieve the above object, the present invention, which provides one kind lactobacillus bulgaricus can be improved, is stored at room temperature ability and resistance to compression energy The freeze drying protectant of power.The constituent of freeze drying protectant are as follows: pregelatinized starch, skimmed milk powder, maltodextrin and trehalose, it is remaining Amount is water.Wherein pregelatinized starch has stronger water imbibition, is able to maintain that the low water activity state of bacterium powder, improves bacterium powder and is storing And the stability in product.Skimmed milk powder, maltodextrin and trehalose can effectively mitigate Freeze-drying Damage and drying stress damage, Improve the freeze-drying survival rate of thallus.
The present invention also provides a specific technical solution, each composition of freeze drying protectant is respectively as follows: pregelatinated by weight 80~120 parts of starch, 50~100 parts of skimmed milk powder, 80~100 parts of maltodextrin, 20~40 parts of trehalose, sterile distilled water 640~770 parts.
Another object of the present invention is to provide a kind of raising lactobacillus bulgaricus and is stored at room temperature ability and anti-pressure ability Freeze-dried vaccine powder preparation technique, includes the following steps:
1. after lactobacillus bulgaricus is activated, carrying out amplification fermentation training step by step according to the inoculum concentration of 5-10% (v/v) It supports, thallus is collected by centrifugation, according to bacterium mud: freeze drying protectant is that the weight ratio of 1:1~3 is sufficiently mixed, and is made Machine liquid in freeze-drying.
2. upper machine liquid, which will be lyophilized, pours into freeze-drying pallet, upper machine liquid thickness control is in 0.5~2.0cm, at -35 DEG C~-45 DEG C It is put into pre-freeze 4-8h in freeze dryer.
3. drying process vacuum degree controls between 0.1-0.3mbar always, primary drying process is according to 0.5~3 DEG C/h Rate be warming up to 0 DEG C.Parsing-desiccation process is warming up to 30 DEG C from 0 DEG C according to the rate of 1~4 DEG C/h, maintains 2-4h.
4. after vacuum freeze drying, bacterium powder crush to be packed into seal in aluminium plastic bag and is stored and -20 DEG C.
The advantage of the invention is that by the optimization of screening and lyophilized technique to lactobacillus bulgaricus freeze drying protectant, Being stored at room temperature for lactobacillus bulgaricus bacterium powder is realized, significantly improves it in the anti-pressure ability of subsequent tablet process, Be conducive to steady production, improve production efficiency, reduces and produce and sell cost.
Specific embodiment
The present invention is further described in detail With reference to embodiment, and the embodiment provided is only for explaining The bright present invention, the range being not intended to be limiting of the invention.Experimental method in following embodiments is unless otherwise specified Conventional method.Material as used in the following examples, bacterial strain, reagent etc., are commercially available unless otherwise specified.
The preparation of 1. freeze drying protectant of embodiment and freeze-dried vaccine powder
Each composition of freeze drying protectant is respectively as follows: 100 parts of pregelatinized starch, 50 parts of skimmed milk powder, maltodextrin by weight 80 parts, 20 parts of trehalose, 750 parts of sterile distilled water.
Freeze-dried vaccine powder preparation technique, after including the following steps: that lactobacillus bulgaricus is activated, according to 5-10% (v/ V) inoculum concentration is amplified fermented and cultured step by step, thallus is collected by centrifugation, according to bacterium mud: freeze drying protectant 1:2 Weight ratio sufficiently mixed, the upper machine liquid of freeze-drying is made.Upper machine liquid will be lyophilized and pour into freeze-drying pallet, upper machine liquid thickness control exists 1.5cm is put into pre-freeze 6h in freeze dryer at -40 DEG C.Drying process vacuum degree is controlled always in 0.2mbar, primary drying process 0 DEG C is warming up to according to the rate of 2 DEG C/h.Parsing-desiccation process is warming up to 30 DEG C from 0 DEG C according to the rate of 3 DEG C/h, maintains 3h.Very After vacuum freecing-dry, bacterium powder crush to be packed into seal in aluminium plastic bag and deposits in -20 DEG C.
The preparation of 2. freeze drying protectant of embodiment and freeze-dried vaccine powder
Each composition of freeze drying protectant is respectively as follows: 120 parts of pregelatinized starch, 60 parts of skimmed milk powder, maltodextrin by weight 80 parts, 40 parts of trehalose, 700 parts of sterile distilled water.
Freeze-dried vaccine powder preparation technique, after including the following steps: that lactobacillus bulgaricus is activated, according to 5-10% (v/ V) inoculum concentration is amplified fermented and cultured step by step, thallus is collected by centrifugation, according to bacterium mud: freeze drying protectant 1:3 Weight ratio sufficiently mixed, the upper machine liquid of freeze-drying is made.Upper machine liquid will be lyophilized and pour into freeze-drying pallet, upper machine liquid thickness control exists 1.5cm is put into pre-freeze 4-8h in freeze dryer at -40 DEG C.Drying process vacuum degree controls between 0.2mbar always, primary dry Dry process is warming up to 0 DEG C according to the rate of 2 DEG C/h.Parsing-desiccation process is warming up to 30 DEG C from 0 DEG C according to the rate of 3 DEG C/h, dimension Hold 3h.After vacuum freeze drying, bacterium powder crush to be packed into seal in aluminium plastic bag and is stored and -20 DEG C.
3. lactobacillus bulgaricus bacterium powder of embodiment is stored at room temperature stability test
Lactobacillus bulgaricus bacterium powder with the preparation of existing bacterium powder production technology is control, freeze drying protectant composition: de- 180 parts of fat milk powder, 60 parts of lactose, 60 parts of yeast powder, 700 parts of sterile distilled water;Lyophilized technique: drying process vacuum degree is controlled always System is between 0.2mbar, and -60 DEG C of pre-freezing temperature, pre-freeze time 10h, primary drying process is warming up to 0 according to the rate of 4 DEG C/h ℃.Parsing-desiccation process is warming up to 25 DEG C from 0 DEG C according to the rate of 2 DEG C/h, maintains 3h.
Investigate the stability that Examples 1 and 2 preparation bacterium powder is stored 8 weeks under the conditions of 25 DEG C.Its test result (table 1) is aobvious Show, compared with the control group, the ability that is stored at room temperature of Examples 1 and 2 preparation bacterium powder significantly improves.
1 lactobacillus bulgaricus bacterium powder of table is stored at room temperature stability
4. lactobacillus bulgaricus bacterium powder compression test of embodiment
Lactobacillus bulgaricus bacterium powder with the preparation of existing bacterium powder production technology is control, freeze drying protectant composition: de- 180 parts of fat milk powder, 60 parts of lactose, 60 parts of yeast powder, 700 parts of sterile distilled water;Lyophilized technique: drying process vacuum degree is controlled always System is between 0.2mbar, and -60 DEG C of pre-freezing temperature, pre-freeze time 10h, primary drying process is warming up to 0 according to the rate of 4 DEG C/h DEG C, parsing-desiccation process is warming up to 25 DEG C from 0 DEG C according to the rate of 2 DEG C/h, maintains 3h.
Lactobacillus bulgaricus bacterium powder prepared by control group bacterium powder and embodiment 1,2 is according to 5 × 109The standard of CFU/g It is mixed respectively with auxiliary material, tablet is prepared using high speed tablet press, its resistance to compression is investigated by Viable detection in tablet Ability.The lactobacillus bulgaricus bacterium powder of the display of its test result (table 2), Examples 1 and 2 preparation has stronger resistance to compression energy Power can significantly improve the yield of product.
2 lactobacillus bulgaricus bacterium powder anti-pressure ability of table
5. lactobacillus bulgaricus bacterium powder of embodiment is stored at room temperature stability
Since tablet will be made derived from the bacterium powder of Examples 1 and 2 in embodiment 4, to being stored at room temperature for the tablet of separate sources Stability is investigated, as the result is shown (table 3), and lactobacillus bulgaricus bacterium powder still has higher room temperature after mixing with auxiliary material Hold capacity, product reach storage at normal temperature, transport and the requirement of sale.
3 lactobacillus bulgaricus tablet of table is stored at room temperature stability

Claims (3)

1. a kind of freeze drying protectant for improving lactobacillus bulgaricus and being stored at room temperature ability and anti-pressure ability, which is characterized in that freeze Do protectant constituent are as follows: pregelatinized starch, skimmed milk powder, maltodextrin and trehalose, surplus are water.
2. freeze drying protectant according to claim 1, which is characterized in that each composition of freeze drying protectant is scored by weight Not are as follows: 80~120 parts of pregelatinized starch, 50~100 parts of skimmed milk powder, 80~100 parts of maltodextrin, 20~40 parts of trehalose, 640~770 parts of sterile distilled water.
3. a kind of freeze-dried vaccine powder preparation technique for improving lactobacillus bulgaricus and being stored at room temperature ability and anti-pressure ability, feature exist In including the following steps:
1. after lactobacillus bulgaricus is activated, being amplified fermented and cultured step by step according to the inoculum concentration of 5-10% (v/v), lead to It crosses centrifugation and collects thallus, bacterium mud and freeze drying protectant are sufficiently mixed according to the weight ratio of 1:1~3, be made in freeze-drying Machine liquid;
2. upper machine liquid, which will be lyophilized, pours into freeze-drying pallet, upper machine liquid thickness control is put into 0.5~2.0cm at -35 DEG C~-45 DEG C Pre-freeze 4-8h in freeze dryer;
3. drying process vacuum degree controls between 0.1-0.3mbar always, primary drying process according to 0.5~3 DEG C/h speed Rate is warming up to 0 DEG C;Parsing-desiccation process is warming up to 30 DEG C from 0 DEG C according to the rate of 1~4 DEG C/h, maintains 2-4h;
4. after vacuum freeze drying, bacterium powder crush to be packed into seal in aluminium plastic bag and deposits in -20 DEG C.
CN201910482027.1A 2019-06-04 2019-06-04 Freeze-drying protective agent for improving normal-temperature storage and pressure resistance of lactobacillus bulgaricus and application thereof Active CN110184191B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910482027.1A CN110184191B (en) 2019-06-04 2019-06-04 Freeze-drying protective agent for improving normal-temperature storage and pressure resistance of lactobacillus bulgaricus and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910482027.1A CN110184191B (en) 2019-06-04 2019-06-04 Freeze-drying protective agent for improving normal-temperature storage and pressure resistance of lactobacillus bulgaricus and application thereof

Publications (2)

Publication Number Publication Date
CN110184191A true CN110184191A (en) 2019-08-30
CN110184191B CN110184191B (en) 2023-02-10

Family

ID=67720302

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910482027.1A Active CN110184191B (en) 2019-06-04 2019-06-04 Freeze-drying protective agent for improving normal-temperature storage and pressure resistance of lactobacillus bulgaricus and application thereof

Country Status (1)

Country Link
CN (1) CN110184191B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113621520A (en) * 2021-08-20 2021-11-09 微康益生菌(苏州)股份有限公司 Protective agent for relieving physical extrusion stress damage of probiotic bacteria powder and application thereof
CN113755357A (en) * 2020-06-04 2021-12-07 内蒙古伊利实业集团股份有限公司 Lactobacillus preparation and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2799725A1 (en) * 2009-11-13 2010-05-20 Unistraw Patent Holdings Limited Probiotic compositions, methods and apparatus for their administration
CN102952755A (en) * 2012-11-19 2013-03-06 陕西科技大学 Lactobacillus bulgaricus freeze-drying protecting agent and preparation method thereof
CN108851086A (en) * 2018-06-11 2018-11-23 西北大学 One kind is with micropore starch for protectant active lactic acid bacteria microcapsule and preparation method

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2799725A1 (en) * 2009-11-13 2010-05-20 Unistraw Patent Holdings Limited Probiotic compositions, methods and apparatus for their administration
CN102952755A (en) * 2012-11-19 2013-03-06 陕西科技大学 Lactobacillus bulgaricus freeze-drying protecting agent and preparation method thereof
CN108851086A (en) * 2018-06-11 2018-11-23 西北大学 One kind is with micropore starch for protectant active lactic acid bacteria microcapsule and preparation method

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
周中凯等: "青香蕉淀粉对乳酸菌在冻干和贮存过程中活性的保护效果", 《食品科学》 *
姚卫蓉等: "双歧杆菌活菌粉的制备", 《食品与生物技术》 *
张泽生等: "保加利亚乳杆菌冷冻干燥保护剂的筛选", 《食品工业》 *
白瑛等: "保加利亚乳杆菌B9冷冻保护剂的优化", 《中国奶牛》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113755357A (en) * 2020-06-04 2021-12-07 内蒙古伊利实业集团股份有限公司 Lactobacillus preparation and application thereof
CN113621520A (en) * 2021-08-20 2021-11-09 微康益生菌(苏州)股份有限公司 Protective agent for relieving physical extrusion stress damage of probiotic bacteria powder and application thereof

Also Published As

Publication number Publication date
CN110184191B (en) 2023-02-10

Similar Documents

Publication Publication Date Title
US11202813B2 (en) Lactobacillus rhamnosus bacterium for treatment of e.g. bacterial vaginosis
CN101724623B (en) Lactobacillus casei Zhang microcapsule, preparation method and applications thereof
CN108348559B (en) Lactobacillus paracasei for producing conjugated linoleic acid, nutritional and pharmaceutical preparations containing same, and use thereof
US20040057943A1 (en) Probiotic strains, a process for the selection of them, compositions thereof, and their use
CN113652359B (en) Lactic acid bacteria freeze-dried powder, preparation method and freeze-dried protective agent thereof
CN108782758B (en) Fermented synbiotic goat milk powder and preparation method thereof
CN110607255B (en) Preparation method and application of lactobacillus delbrueckii and direct vat set lactobacillus delbrueckii starter
CN109929779A (en) A kind of probiotics preparation and its preparation method and application containing biologically active peptide
CN102763726A (en) Probiotics yoghourt powder and preparation method thereof
CN112553128B (en) Probiotic freeze-dried powder and preparation method and application thereof
CN110184191A (en) A kind of raising lactobacillus bulgaricus is stored at room temperature and the freeze drying protectant of anti-pressure ability and its application
RU2451067C2 (en) Method for enhancement of bifidobacteria viability in the process of fermented food product storage
CN108018248B (en) Lactobacillus casei capable of regulating flora structural disorder caused by antibiotics
EP3328208B1 (en) Methods for the preparation of fermented products comprising bifidobacteria
CN1089567C (en) Composite microecological health-care food and its preparing process
RU2261909C1 (en) BIFIDUS-BACTERIUM CONSORTIUM OF Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium adolescentis, Bifidobacterium infantis, Bifidobacterium breve USEFUL IN PREPARATION OF FERMENTED-MILK AND NONFERMENTED PRODUCTS, BIOACTIVE SUPPLEMENT, BIFIDOBACTERIA- CONTAINING PRODUCT, COSMETIC AND TOILETRY AGENTS
CN107660670A (en) Bitter buckwheat probiotics drink and preparation method thereof
BG66485B1 (en) Lactobacillus delbrueckii subsp. bulgaricus strain with a wide range of applications
CN108094531A (en) A kind of dual probiotics fermented beverage and preparation method thereof
CN103555801A (en) Method for preparing polypeptide through lactobacillus solid-state fermentation enzymolysis of bean pulps
JP2003527853A (en) How to supply starter culture with consistent quality
RU2273662C2 (en) Consortium of microorganisms with probiotic effect
CN102757923B (en) Method for preparing bifidobacterium bifidum powder with high viable count
CN105815628A (en) Fermented sesame rich in small peptides and processing method thereof
CN107136217A (en) Probiotics fermentation-type yoghurt dry powder electuary and its production technology

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant